View in EDS

PCN87 The Cost Effectiveness of Cetuximab (Erbitux) in the Third Line Treatment of Metastatic Colorectal Cancer in the UK

Saved in:
Bibliographic Details
Title: PCN87 The Cost Effectiveness of Cetuximab (Erbitux) in the Third Line Treatment of Metastatic Colorectal Cancer in the UK
Authors: Perard, R.1, Samyshkin, Y.2, Guillermin, A.L.G.2
Source: Value in Health. pA450-A450. 1p.
Database: Academic Search Ultimate
Description
ISSN:10983015
DOI:10.1016/j.jval.2011.08.1188